Clinical Practice Guidelines on Genitourinary Cancers - ESMO
WEBJan 19, 2022 · ESMO has Clinical Practice Guidelines on the following Genitourinary Cancers: Bladder cancer, Penile cancer, Prostate cancer, Renal cell carcinoma and Testicular cancer. They include information on incidence, diagnosis, staging and risk assessment, treatment, response evaluation and follow-up.
ESMO 2024 - GU Oncology Now
WEBRead in-depth coverage of the ESMO 2024 Congress, featuring the latest research and science on urology from GU oncology experts and key opinion leaders.
ESMO Clinical Practice Guideline interim update on first-line …
WEBMar 13, 2024 · This ESMO Clinical Practice Guideline eUpdate addresses developments in first-line therapy in advanced urothelial carcinoma. •. Enfortumab vedotin–pembrolizumab (EV–P) is the new standard of care in first-line advanced urothelial carcinoma. •.
Current standards and practice changing studies in genitourinary (GU …
WEBMar 7, 2022 · Key words. genitourinary cancer. renal cell carcinoma. urothelial carcinoma. prostate carcinoma. Introduction. The treatment of urological malignancies has seen several significant advancements in recent years.
ESMO 2023 - GU Oncology Now
WEBNov 20, 2023 · Read in-depth coverage of the ESMO 2023 Congress, featuring the latest research and science on urology from GU oncology experts and key opinion leaders.
Practice-changing treatments in GU cancers continue to evolve
WEBSep 5, 2022 · Author of many papers who have revolutionised the treatment algorithms for prostate and testicular cancers, here he discusses how the future of GU cancer management will develop. Your work has been pivotal in prostate cancer with practice-changing studies such as LATITUDE and PEACE-1.
ESMO Congress 2023 | OncologyPRO
WEB23 Oct 2023. Antibody drug conjugates and FGFR-directed therapies: New toxicities. Presenter: Yohann Loriot. Session: Novel targets, therapies and toxicities in genitourinary cancers.
Genitourinary Tract Tumours: Essentials for Clinicians - ESMO
WEBIn the fast-moving field of genitourinary (GU) cancers, ESMO presents the second edition of the Genitourinary Tract Tumours: Essentials for Clinicians. Published in 2020, the book informs on the latest research and up-to-date practice concepts in prostate, urothelial, testicular and kidney cancers, alongside less frequent malignancies such as ...
ESMO | ESMO
WEBSupporting your clinical decisions with ESMO’s regularly updated Clinical Practice Guidelines and consensus recommendations, developed by the leading experts in our profession. Read guidelines by topic.
ESMO 2023: Advances in the Molecular Understanding of GU
WEB(UroToday.com) The 2023 ESMO annual meeting included a session on novel targets, therapies, and toxicities in genitourinary cancers, featuring a presentation by Dr. Samra Turajlic discussing advances in the molecular understanding of genitourinary cancers.